Published on March 16, 2017

Testosterone MDL Judge Sets Schedule for Bellwether Trials

Testosterone MDL Judge Determines Schedule for Bellwether Trials 6,000 testosterone lawsuits are currently pending in Illinois, with the initial eight AndroGel lawsuits scheduled to go to trial in the latter half of 2017.

Plaintiffs typically claim that they took the testosterone replacement drugs, and then …

See original article

Androgel Lawsuits Scheduled for Trial in 2017 fast-paced trial schedule has been established for the first six Androgel lawsuits filed against drug manufacturer AbbVie Inc.

The first bellwether trial has been scheduled for trial in June 2017.

The subsequent cases are expected to begin at four …

Click here for the original story

Actavis Holdco Says FTC’s AndroGel Antitrust Suit Is Moot

Newly acquired Teva subsidiary Actavis Holdco asked a Georgia federal court Friday to end claims against it in an FTC lawsuit alleging pharmaceutical companies illegally conspired to delay generic …

See original article

Testosterone Heart Attack, Blood Clot Bellwether Trials Set lawsuits that allege testosterone drugs caused heart attacks and blood clots will be heading to trial in 2017, according to court documents.

In August 2016, U.S. District Judge Matthew Kennelley signed an order …

These eight bellwether cases …

Read the  DrugWatch post

FTC Wins Access To AndroGel Docs In AbbVie Antitrust Suit

Discovery documents that the drugmaker previously claimed were privileged in the government’s case alleging the company used sham lawsuits against potential rivals Perrigo Co. and Teva Pharmaceutical Industries Ltd. to block generic forms of AndroGel.

See original Law360 article


Leave a Comment

Your email address will not be published. Required fields are marked *